|
(b)(4).During processing of this complaint, attempts were made to obtain complete event, patient and device information.Concomitant medical products: stent: xience alpine (3.0 x 23 mm/3.0 x 08 mm/3.5 x 12 mm).The device was not returned for evaluation.The reported patient effect of myocardial infarction is listed in the xience alpine everolimus eluting coronary stent system instructions for use as a known patient effect of coronary stenting procedures.A conclusive cause for the reported patient effects, and the relationship to the product, if any, cannot be determined.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.There is no indication of a product quality issue with respect to the design, manufacture, or labeling of the device.
|
|
It was reported that the index procedure took place on (b)(6) 2016 during which the following 3.0 x 12 mm, 3.0 x 23 mm, 3.0 x 08 mm and 3.5 x 12 mm xience alpine stents were placed for treatment.The patient was readmitted to the hospital on (b)(6) 2016 experiencing an st myocardial infarction.The patient underwent a surgical procedure during which a pacemaker was implanted.No other information was provided.
|